The stated purpose of my editorial on the patient package insert (PPI) was to inform physicians (and medical students) that PPIs will soon appear for a variety of prescribed drugs, so that physicians might provide some input to the Food and Drug Administration before they appear. From Mr Brody's letter, I gather that this purpose is being accomplished.Mr Brody's assumption that the majority of patients will suffer no anxiety, and this will decrease the number of calls to the physician is an untested hypothesis. Epstein and Lasagna1 once listed all the side effects of a "new" drug and found that not one of their students or staff volunteers would be willing to ingest it; then they told them that the drug was aspirin.I agree that a good PPI may serve some patients and some physicians admirably. My plea was not to keep patients in the
McMahon FG. The "Patient Package Insert"-Reply. JAMA. 1976;235(10):1004. doi:10.1001/jama.1976.03260360013009
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: